Bank of New York Mellon Corp Has $101.78 Million Holdings in Avantor, Inc. (NYSE:AVTR)

Bank of New York Mellon Corp increased its holdings in shares of Avantor, Inc. (NYSE:AVTR) by 1.4% in the 4th quarter, according to its most recent disclosure with the Securities and Exchange Commission. The fund owned 4,830,719 shares of the company’s stock after purchasing an additional 68,598 shares during the quarter. Bank of New York Mellon Corp owned approximately 0.71% of Avantor worth $101,783,000 as of its most recent SEC filing.

A number of other hedge funds have also added to or reduced their stakes in AVTR. MassMutual Private Wealth & Trust FSB lifted its position in Avantor by 99.5% during the 4th quarter. MassMutual Private Wealth & Trust FSB now owns 1,253 shares of the company’s stock worth $26,000 after buying an additional 625 shares in the last quarter. Nisa Investment Advisors LLC increased its position in shares of Avantor by 69.6% in the third quarter. Nisa Investment Advisors LLC now owns 2,035 shares of the company’s stock valued at $53,000 after acquiring an additional 835 shares during the last quarter. Global Retirement Partners LLC raised its holdings in Avantor by 76.7% during the fourth quarter. Global Retirement Partners LLC now owns 2,459 shares of the company’s stock worth $52,000 after acquiring an additional 1,067 shares in the last quarter. UMB Bank n.a. boosted its position in Avantor by 56.3% during the fourth quarter. UMB Bank n.a. now owns 2,981 shares of the company’s stock valued at $63,000 after purchasing an additional 1,074 shares during the last quarter. Finally, CKW Financial Group grew its stake in Avantor by 116.7% in the fourth quarter. CKW Financial Group now owns 5,200 shares of the company’s stock valued at $110,000 after purchasing an additional 2,800 shares in the last quarter. Institutional investors own 95.08% of the company’s stock.

Analysts Set New Price Targets

A number of equities research analysts have recently issued reports on AVTR shares. Raymond James reiterated an “outperform” rating and set a $24.00 price objective (down previously from $26.00) on shares of Avantor in a research note on Monday, February 10th. Stifel Nicolaus dropped their price target on shares of Avantor from $28.00 to $26.00 and set a “buy” rating on the stock in a research report on Monday, February 10th. Royal Bank of Canada decreased their price objective on shares of Avantor from $33.00 to $31.00 and set an “outperform” rating for the company in a research report on Monday, February 10th. Morgan Stanley dropped their target price on shares of Avantor from $27.00 to $25.00 and set an “overweight” rating on the stock in a report on Monday, February 10th. Finally, Barclays cut their target price on shares of Avantor from $26.00 to $23.00 and set an “overweight” rating for the company in a research note on Monday, February 10th. Three analysts have rated the stock with a hold rating and nine have issued a buy rating to the stock. According to MarketBeat, Avantor currently has a consensus rating of “Moderate Buy” and a consensus price target of $25.92.

Avantor Price Performance

Shares of NYSE AVTR opened at $16.71 on Friday. The firm has a market cap of $11.37 billion, a P/E ratio of 16.06, a price-to-earnings-growth ratio of 1.55 and a beta of 1.28. The business’s 50 day moving average is $20.51 and its 200-day moving average is $22.67. The company has a current ratio of 1.07, a quick ratio of 0.70 and a debt-to-equity ratio of 0.54. Avantor, Inc. has a 1-year low of $16.41 and a 1-year high of $28.00.

Avantor (NYSE:AVTR) last posted its earnings results on Wednesday, February 12th. The company reported $0.27 earnings per share for the quarter, topping analysts’ consensus estimates of $0.26 by $0.01. Avantor had a return on equity of 12.17% and a net margin of 10.49%. During the same quarter in the prior year, the company earned $0.22 earnings per share. Equities research analysts predict that Avantor, Inc. will post 1.06 earnings per share for the current year.

Insider Buying and Selling at Avantor

In other Avantor news, CAO Steven W. Eck sold 4,907 shares of Avantor stock in a transaction on Wednesday, February 26th. The stock was sold at an average price of $17.53, for a total value of $86,019.71. Following the completion of the transaction, the chief accounting officer now directly owns 40,604 shares of the company’s stock, valued at $711,788.12. The trade was a 10.78 % decrease in their position. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available at the SEC website. Also, EVP James Bramwell sold 3,758 shares of the stock in a transaction on Wednesday, February 26th. The stock was sold at an average price of $17.53, for a total value of $65,877.74. Following the sale, the executive vice president now directly owns 87,379 shares in the company, valued at approximately $1,531,753.87. This trade represents a 4.12 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders own 1.50% of the company’s stock.

Avantor Company Profile

Avantor, Inc engages in the provision of mission-critical products and services to customers in the biopharma, healthcare, education and government, advanced technologies, and applied materials industries in the Americas, Europe, Asia, the Middle East, and Africa. The company offers materials and consumables, such as purity chemicals and reagents, lab products and supplies, formulated silicone materials, customized excipients, customized single-use assemblies, process chromatography resins and columns, analytical sample prep kits, education and microbiology products, clinical trial kits, peristaltic pumps, and fluid handling tips.